Lu Qi
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Circular RNAs in diseases
- Extracellular vesicles in disease
- RNA modifications and cancer
- RNA Interference and Gene Delivery
Papers in
-
- RNA modifications and cancer 5
- Epigenetics and DNA Methylation 4
- Extracellular vesicles in disease 4
-
- Cancer-related molecular mechanisms research 8
- MicroRNA in disease regulation 4
- Co-authors
- Yanqing Ding (9 shared papers)Yanqing Ding (8 shared papers)Jin Sun (7 shared papers)Kaiyuan Wang (7 shared papers)Hao Ye (7 shared papers)Zhonggui He (6 shared papers)Wenting Liao (4 shared papers)Jian Zhao (5 shared papers)
- Journals
- Journal of Controlled Release (2 papers)Science China Life Sciences (2 papers)Cancer Research (2 papers)Cell Death and Disease (2 papers)Acta Pharmaceutica Sinica B (1 paper)
- Partner nations
- ChinaUnited StatesSwitzerland
In The Last Decade
Lu Qi
50 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 87
- Cancer Research 364
- Molecular Biology 603
- Oncology 199
- Immunology 156
- Biomaterials 83
Countries citing papers authored by Lu Qi
This map shows the geographic impact of Lu Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Qi more than expected).
Fields of papers citing papers by Lu Qi
This network shows the impact of papers produced by Lu Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Qi. The network helps show where Lu Qi may publish in the future.
Co-authors
The 25 scholars most cited alongside Lu Qi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 125 | |
| 2 | 2020 | 109 | |
| 3 | 2013 | 101 | |
| 4 | 2017 | 79 | |
| 5 | 2017 | 62 | |
| 6 | 2023 | 58 | |
| 7 | 2020 | 55 | |
| 8 | 2022 | 51 | |
| 9 | 2021 | 45 | |
| 10 | 2021 | 43 | |
| 11 | 2022 | 39 | |
| 12 | 2019 | 30 | |
| 13 | PABPC1 exerts carcinogenesis in gastric carcinoma by targeting miR-34c. | 2015 | 30 |
| 14 | 2022 | 28 | |
| 15 | 2021 | 27 | |
| 16 | 2023 | 23 | |
| 17 | 2013 | 20 | |
| 18 | 2017 | 14 | |
| 19 | 2014 | 14 | |
| 20 | 2023 | 14 |
About Lu Qi
Lu Qi is a scholar working on Molecular Biology, Cancer Research, Oncology, Pulmonary and Respiratory Medicine and Immunology, having authored 52 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (8 papers), Immunotherapy and Immune Responses (6 papers), Ferroptosis and cancer prognosis (6 papers), Nanoplatforms for cancer theranostics (6 papers), RNA modifications and cancer (5 papers), Epigenetics and DNA Methylation (4 papers), Extracellular vesicles in disease (4 papers) and MicroRNA in disease regulation (4 papers). The work is most often cited by research in Cancer Research (364 citations), Molecular Biology (603 citations), Oncology (199 citations), Immunology (156 citations) and Biomaterials (83 citations). Lu Qi has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Yanqing Ding, Yanqing Ding, Jin Sun, Kaiyuan Wang, Hao Ye, Zhonggui He, Wenting Liao, Jian Zhao, Haotian Zhang and Tingting Li. Their work appears in journals such as Journal of Controlled Release, Science China Life Sciences, Cancer Research, Cell Death and Disease and Acta Pharmaceutica Sinica B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.